FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2063129314> ?p ?o ?g. }

• W2063129314 endingPage "467" @default.
• W2063129314 startingPage "467" @default.
• W2063129314 abstract "To the Editor:We have read with interest the article of Heikkila, Timonen, and Stubb.1Heikkila H Timonen K Stubb S Fixed drug eruption due to fluconazole.J Am Acad Dermatol. 2000; 42: 883-884Abstract Full Text Full Text PDF PubMed Google Scholar We report a new case of fixed drug eruption induced by fluconazole. Clinical history is also typical, but patch tests in our case were negative. An oral provocation was positive and confirmed the diagnosis.A 21-year-old woman consulted us for evaluation of dusky erythematous macules on the left temple, the superior lip, the right palm, and the great toe of the left foot; the lesions had been present for 3 days. The patient was in good health, without any known allergy. Because of recurrent vaginal candidosis, a gynecologist had prescribed fluconazole (1 tablet, 200 mg, once a month). The patient had taken the ninth tablet the day before the eruption developed. Diagnosis of fixed drug eruption was proposed. The lesions disappeared spontaneously. One month later, the patient took the tenth tablet despite medical advice. After a few hours, all lesions reappeared at the same places. Six weeks later, patch tests with fluconazole, ketoconazole, and itraconazole on the back and fluconazole on a previous site of the fixed drug eruption were negative.The drugs most frequently implicated in fixed drug eruptions are trimethoprim-sulfamethoxazole, tetracycline, pyrazolone, sulfadiazine, dipyrone, paracetamol, and aspirin, but many others were reported. The systemic azole antifungal agents are safe; to our knowledge the literature mentions only two cases caused by fluconazole,1Heikkila H Timonen K Stubb S Fixed drug eruption due to fluconazole.J Am Acad Dermatol. 2000; 42: 883-884Abstract Full Text Full Text PDF PubMed Google Scholar, 2Morgan JM Carmichael AJ Fixed drug eruption with fluconazole.BMJ. 1994; 308: 454Crossref PubMed Scopus (32) Google Scholar one case from the use of ketoconazole,3Bharija SC Belhaj MS Ketoconazole-induced fixed drug eruption.Int J Dermatol. 1988; 27: 278-279Crossref PubMed Scopus (13) Google Scholar and none caused by itraconazole.Therefore to our knowledge our case constitutes the third observation of fixed drug eruption induced by fluconazole; it is closely comparable to the first two cases. However, in our case patch tests were negative, and involuntary oral provocation was positive. For fixed drug eruption, sensitivity of the patch test is variable; they are thus useful if positive, but no conclusion is possible if they are negative. If necessary, an oral provocation test may be undertaken; fixed drug eruption is the only drug reaction in which oral provocation is ethically admissible. We thus propose to add fluconazole to the list of drugs that can induce fixed drug eruption. We also pointed out that patch test sensitivity is not 100%; results can be false negative. To the Editor:We have read with interest the article of Heikkila, Timonen, and Stubb.1Heikkila H Timonen K Stubb S Fixed drug eruption due to fluconazole.J Am Acad Dermatol. 2000; 42: 883-884Abstract Full Text Full Text PDF PubMed Google Scholar We report a new case of fixed drug eruption induced by fluconazole. Clinical history is also typical, but patch tests in our case were negative. An oral provocation was positive and confirmed the diagnosis.A 21-year-old woman consulted us for evaluation of dusky erythematous macules on the left temple, the superior lip, the right palm, and the great toe of the left foot; the lesions had been present for 3 days. The patient was in good health, without any known allergy. Because of recurrent vaginal candidosis, a gynecologist had prescribed fluconazole (1 tablet, 200 mg, once a month). The patient had taken the ninth tablet the day before the eruption developed. Diagnosis of fixed drug eruption was proposed. The lesions disappeared spontaneously. One month later, the patient took the tenth tablet despite medical advice. After a few hours, all lesions reappeared at the same places. Six weeks later, patch tests with fluconazole, ketoconazole, and itraconazole on the back and fluconazole on a previous site of the fixed drug eruption were negative.The drugs most frequently implicated in fixed drug eruptions are trimethoprim-sulfamethoxazole, tetracycline, pyrazolone, sulfadiazine, dipyrone, paracetamol, and aspirin, but many others were reported. The systemic azole antifungal agents are safe; to our knowledge the literature mentions only two cases caused by fluconazole,1Heikkila H Timonen K Stubb S Fixed drug eruption due to fluconazole.J Am Acad Dermatol. 2000; 42: 883-884Abstract Full Text Full Text PDF PubMed Google Scholar, 2Morgan JM Carmichael AJ Fixed drug eruption with fluconazole.BMJ. 1994; 308: 454Crossref PubMed Scopus (32) Google Scholar one case from the use of ketoconazole,3Bharija SC Belhaj MS Ketoconazole-induced fixed drug eruption.Int J Dermatol. 1988; 27: 278-279Crossref PubMed Scopus (13) Google Scholar and none caused by itraconazole.Therefore to our knowledge our case constitutes the third observation of fixed drug eruption induced by fluconazole; it is closely comparable to the first two cases. However, in our case patch tests were negative, and involuntary oral provocation was positive. For fixed drug eruption, sensitivity of the patch test is variable; they are thus useful if positive, but no conclusion is possible if they are negative. If necessary, an oral provocation test may be undertaken; fixed drug eruption is the only drug reaction in which oral provocation is ethically admissible. We thus propose to add fluconazole to the list of drugs that can induce fixed drug eruption. We also pointed out that patch test sensitivity is not 100%; results can be false negative. We have read with interest the article of Heikkila, Timonen, and Stubb.1Heikkila H Timonen K Stubb S Fixed drug eruption due to fluconazole.J Am Acad Dermatol. 2000; 42: 883-884Abstract Full Text Full Text PDF PubMed Google Scholar We report a new case of fixed drug eruption induced by fluconazole. Clinical history is also typical, but patch tests in our case were negative. An oral provocation was positive and confirmed the diagnosis. A 21-year-old woman consulted us for evaluation of dusky erythematous macules on the left temple, the superior lip, the right palm, and the great toe of the left foot; the lesions had been present for 3 days. The patient was in good health, without any known allergy. Because of recurrent vaginal candidosis, a gynecologist had prescribed fluconazole (1 tablet, 200 mg, once a month). The patient had taken the ninth tablet the day before the eruption developed. Diagnosis of fixed drug eruption was proposed. The lesions disappeared spontaneously. One month later, the patient took the tenth tablet despite medical advice. After a few hours, all lesions reappeared at the same places. Six weeks later, patch tests with fluconazole, ketoconazole, and itraconazole on the back and fluconazole on a previous site of the fixed drug eruption were negative. The drugs most frequently implicated in fixed drug eruptions are trimethoprim-sulfamethoxazole, tetracycline, pyrazolone, sulfadiazine, dipyrone, paracetamol, and aspirin, but many others were reported. The systemic azole antifungal agents are safe; to our knowledge the literature mentions only two cases caused by fluconazole,1Heikkila H Timonen K Stubb S Fixed drug eruption due to fluconazole.J Am Acad Dermatol. 2000; 42: 883-884Abstract Full Text Full Text PDF PubMed Google Scholar, 2Morgan JM Carmichael AJ Fixed drug eruption with fluconazole.BMJ. 1994; 308: 454Crossref PubMed Scopus (32) Google Scholar one case from the use of ketoconazole,3Bharija SC Belhaj MS Ketoconazole-induced fixed drug eruption.Int J Dermatol. 1988; 27: 278-279Crossref PubMed Scopus (13) Google Scholar and none caused by itraconazole. Therefore to our knowledge our case constitutes the third observation of fixed drug eruption induced by fluconazole; it is closely comparable to the first two cases. However, in our case patch tests were negative, and involuntary oral provocation was positive. For fixed drug eruption, sensitivity of the patch test is variable; they are thus useful if positive, but no conclusion is possible if they are negative. If necessary, an oral provocation test may be undertaken; fixed drug eruption is the only drug reaction in which oral provocation is ethically admissible. We thus propose to add fluconazole to the list of drugs that can induce fixed drug eruption. We also pointed out that patch test sensitivity is not 100%; results can be false negative." @default.
• W2063129314 created "2016-06-24" @default.
• W2063129314 creator A5040122931 @default.
• W2063129314 creator A5043799216 @default.
• W2063129314 date "2002-03-01" @default.
• W2063129314 modified "2023-09-24" @default.
• W2063129314 title "Fixed drug eruption due to fluconazole: A third case" @default.
• W2063129314 cites W1984876016 @default.
• W2063129314 cites W2090210325 @default.
• W2063129314 cites W83327104 @default.
• W2063129314 doi "https://doi.org/10.1067/mjd.2002.118356" @default.
• W2063129314 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11862192" @default.
• W2063129314 hasPublicationYear "2002" @default.
• W2063129314 type Work @default.
• W2063129314 sameAs 2063129314 @default.
• W2063129314 citedByCount "22" @default.
• W2063129314 countsByYear W20631293142012 @default.
• W2063129314 countsByYear W20631293142013 @default.
• W2063129314 countsByYear W20631293142015 @default.
• W2063129314 countsByYear W20631293142018 @default.
• W2063129314 countsByYear W20631293142022 @default.
• W2063129314 crossrefType "journal-article" @default.
• W2063129314 hasAuthorship W2063129314A5040122931 @default.
• W2063129314 hasAuthorship W2063129314A5043799216 @default.
• W2063129314 hasConcept C16005928 @default.
• W2063129314 hasConcept C2779515644 @default.
• W2063129314 hasConcept C2779548794 @default.
• W2063129314 hasConcept C2780035454 @default.
• W2063129314 hasConcept C2780651595 @default.
• W2063129314 hasConcept C71924100 @default.
• W2063129314 hasConcept C98274493 @default.
• W2063129314 hasConceptScore W2063129314C16005928 @default.
• W2063129314 hasConceptScore W2063129314C2779515644 @default.
• W2063129314 hasConceptScore W2063129314C2779548794 @default.
• W2063129314 hasConceptScore W2063129314C2780035454 @default.
• W2063129314 hasConceptScore W2063129314C2780651595 @default.
• W2063129314 hasConceptScore W2063129314C71924100 @default.
• W2063129314 hasConceptScore W2063129314C98274493 @default.
• W2063129314 hasIssue "3" @default.
• W2063129314 hasLocation W20631293141 @default.
• W2063129314 hasLocation W20631293142 @default.
• W2063129314 hasOpenAccess W2063129314 @default.
• W2063129314 hasPrimaryLocation W20631293141 @default.
• W2063129314 hasRelatedWork W2048020101 @default.
• W2063129314 hasRelatedWork W2072259960 @default.
• W2063129314 hasRelatedWork W2090210325 @default.
• W2063129314 hasRelatedWork W2096879039 @default.
• W2063129314 hasRelatedWork W2217480807 @default.
• W2063129314 hasRelatedWork W2337537501 @default.
• W2063129314 hasRelatedWork W2415080706 @default.
• W2063129314 hasRelatedWork W3177322434 @default.
• W2063129314 hasRelatedWork W4240359496 @default.
• W2063129314 hasRelatedWork W4297184974 @default.
• W2063129314 hasVolume "46" @default.
• W2063129314 isParatext "false" @default.
• W2063129314 isRetracted "false" @default.
• W2063129314 magId "2063129314" @default.
• W2063129314 workType "article" @default.